1. Insulin-like growth factor binding protein 3 chemosensitizes pancreatic ductal adenocarcinoma through its death receptor
   Mohammad Reza Mofid et al, 2020, Pancreatology CrossRef
2. Liposomal curcumin alters chemosensitivity of breast cancer cells to Adriamycin via regulating microRNA expression
   Siying Zhou et al, 2017, Gene CrossRef
3. Uricase sensitizes hepatocellular carcinoma cells to 5-fluorouracil through uricase-uric acid-UMP synthase axis
   Saihong Yu et al, 2022, Journal of Physiology and Biochemistry CrossRef
4. Establishment and Characterization of a New Intrahepatic Cholangiocarcinoma Cell Line Resistant to Gemcitabine
   Chiara Varamo et al, 2019, Cancers CrossRef
5. Chemoresistance in Pancreatic Cancer
   Siyuan Zeng et al, 2019, International Journal of Molecular Sciences CrossRef
6. Identification of chemoresistance‐related mRNAs based on gemcitabine‐resistant pancreatic cancer cell lines
   Jiarong Zhou et al, 2020, Cancer Medicine CrossRef
7. Inhibiting RRM2 to enhance the anticancer activity of chemotherapy
   Yaqiong Zhan et al, 2021, Biomedicine & Pharmacotherapy CrossRef
8. Therapeutic resistance of pancreatic cancer: Roadmap to its reversal
   Sen Yu et al, 2021, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
9. STIM1 Mediates Calcium-Dependent Epigenetic Reprogramming in Pancreatic Cancer
   Ana P. Kutschat et al, 2021, Cancer Research CrossRef
10. A Self‐Assembly Combined Nano‐Prodrug to Overcome Gemcitabine Chemo‐Resistance of Pancreatic Tumors
    Zhuo Yao et al, 2023, Advanced Functional Materials CrossRef
11. Pancreatic Cancer Chemoresistance to Gemcitabine
    Manoj Amrutkar et al, 2017, Cancers CrossRef
12. Deciphering the Role of Exosomal Non-Coding RNA (ncRNA) in Drug Resistance of Gastrointestinal Tumors; an Updated Review
    Nafiseh Tashakori et al, 2024, Cell Biochemistry and Biophysics CrossRef
13. Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learning
    Stephanie N. Dorman et al, 2016, Molecular Oncology CrossRef
14. Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancer
    Masahiro Uehara et al, 2024, Cancer Drug Resistance CrossRef
15. Vascular impairment of adenosinergic system in hypertension: increased adenosine bioavailability and differential distribution of adenosine receptors and nucleoside transporters
    Ana Sousa-Oliveira et al, 2019, Histochemistry and Cell Biology CrossRef
16. Research advances of intracellular mechanisms underlying gemcitabine resistance in pancreatic cancer
    Zong-Ting Gu et al, 2020, World Chinese Journal of Digestology CrossRef
17. Precision medicine in the treatment of pancreatic ductal adenocarcinoma
    Jianlin Chen et al, 2016, Oncology and Translational Medicine CrossRef
18. Gemcitabine effects on tumor microenvironment of pancreatic ductal adenocarcinoma: Special focus on resistance mechanisms and metronomic therapies
    Jay Natu et al, 2023, Cancer Letters CrossRef
19. Therapeutic resistance in pancreatic ductal adenocarcinoma: Current challenges and future opportunities
    Aditi Jain et al, 2021, World Journal of Gastroenterology CrossRef
20. Novel Mechanistic Insight into the Anticancer Activity of Cucurbitacin D against Pancreatic Cancer (Cuc D Attenuates Pancreatic Cancer)
    Mohammed Sikander et al, 2019, Cells CrossRef
21. Tissue-Specific Human Extracellular Matrix Scaffolds Promote Pancreatic Tumour Progression and Chemotherapy Resistance
    Walid Al-Akkad et al, 2022, Cells CrossRef